ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0380

Use of Telemedicine by Kidney Care Providers for Patients on Hemodialysis

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Erickson, Kevin F., Baylor College of Medicine, Houston, Texas, United States
  • Winkelmayer, Wolfgang C., Baylor College of Medicine, Houston, Texas, United States
  • Niu, Jingbo, Baylor College of Medicine, Houston, Texas, United States
Background

The federal emergency waivers in March 2020 in the United States (US) enabled kidney care providers to substitute face-to-face in-center hemodialysis (HD) visits with telemedicine encounters. While the use of telemedicine facilitated maintaining of visit frequency of providers during the COVID-19 pandemic, how it affected the HD-related outcomes of patients was unknown.

Methods

We used national Medicare claims data to identify US patients receiving in-center HD at DaVita, one of the large facility chains, during the first 6 months of the pandemic, from 4/1/2020-9/30/2020. We focused on patients of providers who demonstrated knowledge of how to bill for telemedicine visits, i.e., making at least one telemedicine bill in the first 3 months of the period. We compared HD-related outcomes among patients of providers with high-level vs. low-level use of telemedicine. Multivariable regression models adjusted for Covid-19 rate, patient, physician, geographic and dialysis facility characteristics along with the HD-related outcome level before the pandemic.

Results

Among the 13,108 in-center HD patients identified, 35% were from providers with higher-level telemedicine. In fully adjusted models, the higher telemedicine group had 0.7% lower absolute probability of serum albumin < 3.5 g/dL (95% CI: -1.3%, -0.1%, p=0.02) and 1.4% lower probability of serum phosphate >5.5 mg/dL (95% CI: -2.5%, -0.2%, p=0.02). No significant difference between the two groups was observed on average mean blood pressure between dialysis, inter-HD weight gain, and other dichotomous outcomes and count measure (Figure 1).

Conclusion

Higher use of telemedicine among in-center HD patients did not affect most HD-related outcomes, and was related to a slightly lower chance of low albumin and high phosphate.

Funding

  • NIDDK Support

Digital Object Identifier (DOI)